|
Health Condition(s) or Problem
|
Osteoarthritis
|
|
Lay Summary
|
Not provided at time of registration (from ISRCTN)
|
|
Who can enter the trial
|
1. 18 years of age or over
2. Diagnosis of osteoarthritis
3. In receipt of prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and opioid/opioid compound analgesic medication
4. Responsible for administering own medication
5. Reporting pain associated with osteoarthritis
|
|
Who cannot enter the trial
|
1. Confounding medical condition/disease
2. Pain lasting less than 6 weeks in total duration prior to recruitment
3. Pacemaker, insulin pump or similar device fitted
4. Pregnant women
|
|
What will happen
|
The trial will use a randomised double-blind placebo controlled crossover design. All participants will undertake one of four randomly allocated treatment sequences consisting of four phases (one active and three control). During the active phase participants will wear the MagnaMax® static magnetic device for a period of four weeks. During the three control (placebo) phases, which will each last for four weeks, all participants will in turn wear: an otherwise identical low strength static magnetic device, a demagnetised device and a copper bracelet.
|
|
Primary aim
|
Not provided at time of registration
|
|
Secondary Aim
|
Not provided at time of registration
|
|
Participant Information Sheet
|
Trial participant information is available on http://www.hull.ac.uk/macropod/info.htm
|
|
Website
|
http://www.hull.ac.uk/macropod/
|
|
Recruitment Status
|
Completed
|
|
Nation
|
England
|
|
Location
|
Hull
|